Results 191 to 200 of about 55,565 (283)

Targeting Sphingosine‐1‐Phosphate Signaling Attenuates Doxorubicin‐Aggravated Bone Loss in Obese Breast Cancer Mice

open access: yesSmart Medicine, Volume 5, Issue 2, April 2026.
During obese breast cancer‐bearing mice undergoing chemotherapy, DOX increases the concentration of S1P produced by breast cancer cells, which induces osteoclastogenesis through the activation of the S1PR1/p‐STAT3/NFATc‐1 pathway, thereby exacerbating bone loss in the breast cancer‐bearing mice with high‐fat dietary.
Yu Zhang   +12 more
wiley   +1 more source

A concept for a new approach to combined oral contraception from adolescence to perimenopause: Continuous use of the oral GnRH antagonist Relugolix and the fetal estrogen Estetrol

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 4, Page 568-574, April 2026.
It is expected that the relugolix estetrol combination RE4W will enable women to control their fertility and prevent menstrual cycle related problems, while offering a smooth transition through perimenopause into the postmenopause and decrease the risk of breast cancer.
Herjan J. T. Coelingh Bennink   +9 more
wiley   +1 more source

Microbe-associated molecular patterns differentially mediate carcinogenic alterations of the breast tissue in the context of obesity. [PDF]

open access: yesNeoplasia
Gaber M   +10 more
europepmc   +1 more source

Kisspeptin Restores Placental mTOR Signaling and Improves Glucose Homeostasis Mediators Disrupted by Maternal Hypothyroidism in Rats

open access: yesActa Physiologica, Volume 242, Issue 4, April 2026.
ABSTRACT Aim Reduced placental mTOR signaling is associated with intrauterine growth restriction and impaired maternal and placental metabolism. Since maternal hypothyroidism induces intrauterine growth restriction, and maternal treatment with kisspeptin‐10 (Kp10) has been shown to improve feto‐placental development in hypothyroid rats, this study ...
Bianca Reis Santos   +9 more
wiley   +1 more source

Trefoil Factor‐3 Is a Hypoxia‐Triggered Pro‐Tumorigenic Factor in Hepatoblastoma

open access: yesLiver International, Volume 46, Issue 4, April 2026.
ABSTRACT Background & Aims Hepatoblastoma (HB) is the most common malignant liver tumour in children. Despite improved survival in low‐risk disease, outcomes for advanced or relapsed HB remain poor, emphasising the need for new therapeutic targets.
Luz A. Martínez‐Pérez   +25 more
wiley   +1 more source

Phytosphingosine contributes gut microbiota metabolism to alleviate low-grade endotoxemia-induced mastitis. [PDF]

open access: yesMicrobiome
Zhao Y   +16 more
europepmc   +1 more source

Evaluating the Efficacy of Polyphenol‐Enriched Plant Extracts and Pathway Modulators in the Bone Marrow to Suppress Breast Cancer Progression

open access: yesThe FASEB Journal, Volume 40, Issue 6, 31 March 2026.
The combined therapy decreased inflammatory and angiogenic signaling and altered bone marrow cell profiles linked to tumor dormancy, indicating a potential approach to limit disease progression and reduce relapse risk in breast cancer. ABSTRACT Disseminated tumor cells (DTCs) in the bone marrow can survive in a dormant state and later reawaken to drive
Hayarpi Javrushyan   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy